A new class of drug for type 2 diabetes could save thousands of lives each year, a study has found.
Researchers described the once-daily SGLT-2 inhibitor tablets as working “very well” for a wide range of patients.
A new class of drug for type 2 diabetes could save thousands of lives each year, a study has found.
Researchers described the once-daily SGLT-2 inhibitor tablets as working “very well” for a wide range of patients.